NanoVation Therapeutics
NanoVation Therapeutics is seeking a Scientist I, Preclinical to join their team for a 12-month contract in Vancouver, Canada. This role focuses on designing, executing, and analyzing preclinical research to advance the company's lipid nanoparticle therapeutic delivery projects. The position involves leading project teamwork, mentoring team members, and contributing to the development of novel research opportunities and patentable ideas.
Headquarters
Vancouver, British Columbia, Canada
Company Size
11-50 employees
Founded
2020
NanoVation Therapeutics develops delivery solutions to enable genetic medicines. They specialize in customized lipid nanoparticle (LNP) formulations tailored to specific targets, payloads and routes of administration to improve the safety and efficiency of gene therapies. Their platform is designed to help therapeutic developers optimize delivery for diverse cargos and clinical needs.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for NanoVation Therapeutics.
Scientist III, Preclinical-12 month contract
Nanovation
Contract SRA / Scientist, Lipid Nanoparticle (LNP) Discovery
Addition Therapeutics
Associate Scientist, Delivery Sciences
Intellia Therapeutics
Scientist II, LNP
CRISPR Therapeutics
Postdoctoral Research Associate - Therapeutic Genome Engineering
St. Jude Children's Research Hospital
Research Associate, Preclinical
Acuitas Therapeutics